By Finance Pulse in KeyInfo —

Gilenya Sales Plummet from $3.22B to $925M in Four Years

Gilenya faces a steep sales decline in the pharmaceutical market, dropping from $3.22 billion in 2019 to $925 million in 2023 due to increased competition.

A graph declining sharply against a backdrop of pharmaceutical pills, symbolizing the drop in Gileny
Gilenya Sales Plummet from $3.22B to $925M in Four Years

Gilenya's sales have been declining, with sales falling to $925 million in 2023 from $3.22 billion in 2019.

Source